{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:43:11Z","timestamp":1791297791928,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.bpg.2012.09.009","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:18:03Z","timestamp":1354148283000},"page":"401-412","source":"Crossref","is-referenced-by-count":208,"title":["Natural history of acute and chronic hepatitis C"],"prefix":"10.1016","volume":"26","author":[{"given":"Benjamin","family":"Maasoumy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infec"},{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"55","author":"EASL","year":"2011","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib3","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis c virus infection: 2011 practice guideline by the american association for the study of liver diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bpg.2012.09.009_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2009.12.028","article-title":"Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis","volume":"52","author":"Cardoso","year":"2010","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","article-title":"Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine","volume":"12","author":"Grebely","year":"2012","journal-title":"Lancet Infec Dis"},{"issue":"7","key":"10.1016\/j.bpg.2012.09.009_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/QAD.0b013e3283454174","article-title":"The natural history of liver cirrhosis in HIVhepatitis C virus-coinfected patients","volume":"25","author":"Lopez-Dieguez","year":"2011","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.20742","article-title":"Viral and host factors in early hepatitis C virus infection","volume":"42","author":"Mosley","year":"2005","journal-title":"Hepatology"},{"issue":"31","key":"10.1016\/j.bpg.2012.09.009_bib9","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1002\/hep.510260703","article-title":"Hepatitis C: the clinical spectrum of disease","volume":"26","author":"Hoofnagle","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJM199107113250205","article-title":"A long-term study of hepatitis C virus replication in non-A, non-B hepatitis","volume":"325","author":"Farci","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/jhep.2003.50310","article-title":"Kinetics of the immune response during HBV and HCV infection","volume":"38","author":"Bertoletti","year":"2003","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.bpg.2012.09.009_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/428578","article-title":"Prospective evaluation of community-acquired acute-phase hepatitis C virus infection","volume":"40","author":"Cox","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.bpg.2012.09.009_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1055\/s-0028-1109149","article-title":"The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection","volume":"47","author":"Deterding","year":"2009","journal-title":"Z Gastroenterol"},{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/jhep.2001.22112","article-title":"Acute hepatitis C","volume":"33","author":"Orland","year":"2001","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2036.2010.04549.x","article-title":"The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes","volume":"33","author":"Loomba","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/600058","article-title":"Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection","volume":"49","author":"Vogel","year":"2009","journal-title":"Clin Infec Dis"},{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection:the HEP-NET acute-HCV-II study","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.","volume":"6","author":"Takaki","year":"2000","journal-title":"Nature Medicine"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.005","article-title":"Acute hepatitis C: current status and remaining challenges","volume":"49","author":"Santantonio","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jac\/dkn346","article-title":"Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha","volume":"62","author":"Wiegand","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"5 Suppl. 1","key":"10.1016\/j.bpg.2012.09.009_bib21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/hep.1840360702","article-title":"National institutes of health consensus development conference: management of hepatitis C: 2002","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bpg.2012.09.009_bib22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/gut.2005.078147","article-title":"Higher clearance of hepatitis C virus infection in females compared with males","volume":"55","author":"Bakr","year":"2006","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2893.2011.01497.x","article-title":"IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection","volume":"19","author":"Rao","year":"2012","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2010.12.027","article-title":"Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C","volume":"140","author":"Villa","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archinte.158.2.177","article-title":"Age-related response to interferon alfa treatment in women vs men with chronic hepatitis C virus infection","volume":"158","author":"Hayashi","year":"1998","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.bpg.2012.09.009_bib26","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1056\/NEJM199909163411202","article-title":"Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening","volume":"341","author":"Vogt","year":"1999","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bpg.2012.09.009_bib27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1440-1746.2004.03463.x","article-title":"Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children","volume":"19","author":"Rerksuppaphol","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"issue":"10","key":"10.1016\/j.bpg.2012.09.009_bib29","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1086\/522608","article-title":"Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance","volume":"196","author":"Wang","year":"2007","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.bpg.2012.09.009_bib30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J Clin Inves"},{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2010.11.030","article-title":"Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+NK cells in acute HCV infection may predict viral clearance","volume":"55","author":"Alter","year":"2011","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.bpg.2012.09.009_bib32","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/infdis\/jis210","article-title":"Interferon alpha-Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1","volume":"205","author":"Stegmann","year":"2012","journal-title":"J Infect Dis"},{"issue":"5685","key":"10.1016\/j.bpg.2012.09.009_bib33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"issue":"7262","key":"10.1016\/j.bpg.2012.09.009_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"issue":"7265","key":"10.1016\/j.bpg.2012.09.009_bib35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib36","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib37","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in il28b is associated with chronic hepatitis c and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2012.03.020","article-title":"Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: A model-based analysis","volume":"57","author":"Deuffic-Burban","year":"2012","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.bpg.2012.09.009_bib39","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group","volume":"42","author":"Cacoub","year":"1999","journal-title":"Multidepartment Virus C. Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.dld.2006.06.008","article-title":"Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach","volume":"39","author":"Zignego","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"3\u20134","key":"10.1016\/j.bpg.2012.09.009_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/B:MEBR.0000043982.17294.9b","article-title":"Hepatitis C virus-associated extrahepatic manifestations: a review","volume":"19","author":"Sene","year":"2004","journal-title":"Metab Brain Dis"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00108-007-2014-7","article-title":"[Hepatitis associated cryoglobulinemia]","volume":"49","author":"Pischke","year":"2008","journal-title":"Internist (Berl)"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib44","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2007.06.064","article-title":"Natural history and clinical impact of cryoglobulins in chronic hepatitis C: 10-year prospective study of 343 patients","volume":"133","author":"Vigano","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bpg.2012.09.009_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib47","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bpg.2012.09.009_bib48","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.2337\/dc06-0456","article-title":"Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection","volume":"29","author":"Sim\u00f3","year":"2006","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.bpg.2012.09.009_bib49","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/hep.22251","article-title":"Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus","volume":"47","author":"Veldt","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1478-3231.2009.02185.x","article-title":"Hepatitis C and diabetes: one treatment for two diseases?","volume":"30","author":"Pattullo","year":"2010","journal-title":"Liver Int"},{"issue":"9301","key":"10.1016\/j.bpg.2012.09.009_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(02)07339-7","article-title":"Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening","volume":"359","author":"Ishizaka","year":"2002","journal-title":"Lancet: England"},{"issue":"8","key":"10.1016\/j.bpg.2012.09.009_bib52","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gut.2009.202317","article-title":"Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors","volume":"59","author":"Mostafa","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib53","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jhep.2004.07.022","article-title":"Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy","volume":"41","author":"Weissenborn","year":"2004","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/gut.2010.217976","article-title":"Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy","volume":"60","author":"Bokemeyer","year":"2011","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib55","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jhep.2005.04.007","article-title":"Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany \u2013 a 25-year multicenter study","volume":"43","author":"Wiese","year":"2005","journal-title":"J Hepatol"},{"issue":"9055","key":"10.1016\/j.bpg.2012.09.009_bib56","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpg.2012.09.009_bib57","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and metaregression","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib58","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2012.09.009_bib59","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0168-8278(12)60010-5","article-title":"Antiviral strategies in hepatitis C virus infection","volume":"56","author":"Sarrazin","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa1104430","article-title":"Preliminary study of two antiviral agents for hepatitis C genotype 1","volume":"366","author":"Lok","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0168-8278(02)00413-0","article-title":"A comparison of fibrosis progression in chronic liver diseases","volume":"38","author":"Poynard","year":"2003","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gut.2003.021691","article-title":"Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study","volume":"53","author":"Ryder","year":"2004","journal-title":"Gut"},{"issue":"80","key":"10.1016\/j.bpg.2012.09.009_bib63","first-page":"2324","article-title":"Older age at the time of liver biopsy is the important risk factor for advanced fibrosis in patients with chronic hepatitis C","volume":"54","author":"Svirtlih","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0168-8278(02)00387-2","article-title":"Rate of natural disease progression in patients with chronic hepatitis C","volume":"38","author":"Zarski","year":"2003","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1478-3231.2006.01430.x","article-title":"Progression to cirrhosis in hepatitis C patients: an age-dependent process","volume":"27","author":"Pradat","year":"2007","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1440-1746.2008.05649.x","article-title":"Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India","volume":"24","author":"Hissar","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib67","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hep.510290307","article-title":"Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats","volume":"29","author":"Yasuda","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bpg.2012.09.009_bib68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1542-3565(04)00164-8","article-title":"A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans","volume":"2","author":"Sterling","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib69","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1572-0241.2002.05555.x","article-title":"Hepatitis C infection in African Americans: its natural history and histological progression","volume":"97","author":"Wiley","year":"2002","journal-title":"The American journal of gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib70","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gut.48.5.714","article-title":"Low frequency of HLA-DRB1* 11 in hepatitis C virus induced end stage liver disease","volume":"48","author":"Tillmann","year":"2001","journal-title":"Gut"},{"issue":"9196","key":"10.1016\/j.bpg.2012.09.009_bib71","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(99)91443-5","article-title":"Influence of MHC class II genotype on outcome of infection with hepatitis C virus","volume":"354","author":"Thursz","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bpg.2012.09.009_bib72","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2006.02.032","article-title":"Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C","volume":"130","author":"Huang","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib73","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/hep.23111","article-title":"A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C","volume":"50","author":"Marcolongo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2012.09.009_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(11)60126-8","article-title":"Impact of pnpla3 (Rs738409 C > G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.","volume":"54","author":"Trepo","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0168-8278(03)00004-7","article-title":"A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase","volume":"38","author":"Hui","year":"2003","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib76","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.510270333","article-title":"Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity","volume":"27","author":"Mathurin","year":"1998","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib77","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2893.2011.01485.x","article-title":"Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma","volume":"19","author":"Puoti","year":"2012","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.bpg.2012.09.009_bib78","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2009.05.016","article-title":"Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.","volume":"51","author":"Bochud","year":"2009","journal-title":"Journal of hepatology"},{"issue":"11","key":"10.1016\/j.bpg.2012.09.009_bib79","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2893.2011.01481.x","article-title":"Role of hepatitis C virus genotype 3 in liver fibrosis progression\u2013a systematic review and metaanalysis","volume":"18","author":"Probst","year":"2011","journal-title":"J Viral Hepat"},{"issue":"6","key":"10.1016\/j.bpg.2012.09.009_bib80","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cgh.2011.03.004","article-title":"A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.","volume":"9","author":"Backus","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib81","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/gut.2004.048009","article-title":"Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients","volume":"54","author":"Rumi","year":"2005","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib82","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.510290310","article-title":"Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population","volume":"29","author":"Fanning","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcv.2011.09.029","article-title":"Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy","volume":"53","author":"Maylin","year":"2012","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.bpg.2012.09.009_bib84","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.humpath.2004.04.017","article-title":"Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens","volume":"35","author":"Brunt","year":"2004","journal-title":"Human pathology"},{"issue":"7","key":"10.1016\/j.bpg.2012.09.009_bib85","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","article-title":"Hepatitis C virus core protein induces hepatic steatosis in transgenic mice","volume":"78","author":"Moriya","year":"1997","journal-title":"J General Virol"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib86","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0168-8278(12)60007-5","article-title":"The interaction of metabolic factors with HCV infection: does it matter?","volume":"56","author":"Bugianesi","year":"2012","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib87","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/hep.23162","article-title":"Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C","volume":"50","author":"Freedman","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.bpg.2012.09.009_bib88","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2011.02.061","article-title":"Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C","volume":"140","author":"Freedman","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bpg.2012.09.009_bib89","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005","volume":"27","author":"Altekruse","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.bpg.2012.09.009_bib90","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","article-title":"The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update","volume":"139","author":"El-Serag","year":"2003","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.bpg.2012.09.009_bib91","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1053\/j.gastro.2006.01.032","article-title":"Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality","volume":"130","author":"Tanaka","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hep.22312","article-title":"Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004","volume":"48","author":"Bosetti","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib93","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","article-title":"Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease","volume":"136","author":"Lok","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bpg.2012.09.009_bib94","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients","volume":"43","author":"Sangiovanni","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib95","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-8278(97)80302-9","article-title":"Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP)","volume":"27","author":"Fattovich","year":"1997","journal-title":"J Hepatol"},{"issue":"5 Suppl. 1","key":"10.1016\/j.bpg.2012.09.009_bib96","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib97","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.2003.020263","article-title":"Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications","volume":"53","author":"Benvegnu","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib98","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gut.47.1.131","article-title":"Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death","volume":"47","author":"Degos","year":"2000","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib99","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ajg.2011.384","article-title":"Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study","volume":"107","author":"Lai","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib100","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2002.36780","article-title":"Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus","volume":"36","author":"Hassan","year":"2002","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bpg.2012.09.009_bib101","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/14656561003637659","article-title":"Treatment of HBV\/HCV coinfection","volume":"11","author":"Potthoff","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib102","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"Kumar","year":"2011","journal-title":"Nature genetics"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jhep.2010.01.033","article-title":"Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study","volume":"53","author":"Omland","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhep.2010.01.036","article-title":"Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia","volume":"53","author":"Gidding","year":"2010","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2012.09.009_bib105","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2004.01.005","article-title":"Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients","volume":"40","author":"Planas","year":"2004","journal-title":"J Hepatol"},{"issue":"23","key":"10.1016\/j.bpg.2012.09.009_bib106","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa0707615","article-title":"Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon","volume":"359","author":"Di Bisceglie","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.bpg.2012.09.009_bib107","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1053\/j.gastro.2011.03.010","article-title":"Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C","volume":"140","author":"Bruix","year":"2011","journal-title":"Gastroenterology"},{"issue":"22","key":"10.1016\/j.bpg.2012.09.009_bib108","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199506013322202","article-title":"Clinical outcomes after transfusion associated hepatitis C","volume":"332","author":"Tong","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jhep.2006.07.029","article-title":"Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins:long-term follow-up of 196 patients (4535 patient-years)","volume":"46","author":"de Ledinghen","year":"2007","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2012.09.009_bib110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/jhep.2000.8169","article-title":"Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicentre study","volume":"32","author":"Wiese","year":"2000","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.bpg.2012.09.009_bib111","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group","volume":"340","author":"Kenny-Walsh","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691812000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691812000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T23:28:27Z","timestamp":1540078107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691812000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1521691812000923"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2012.09.009","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}